It is with great honor that we announce the promotion of Dr. Stephanie Shrader as Director of General Toxicologic Pathology at StageBio.
As Director of General Toxicologic Pathology, Dr. Stephanie will support StageBio’s mission by:
- Overseeing the StageBio General Toxicologic Pathology Division
- Collaborating with leadership, including providing developmental support of short and long-term objectives
- Providing strategic insight to identifying new growth channels
- Working with the commercial team to further develop StageBio’s visibility, presence, and networking opportunities
“Dr. Stephanie Shrader has been an important part of our success at StageBio, we are thrilled to congratulate her on her promotion as Director of General Toxicologic Pathology. Through her strategic focus, subspecialty interest in ocular pathology and commitment to StageBio, she has been an exceptional leader. I look forward to reaching new levels of growth at StageBio with her increased involvement in leadership.” – Lori Ball, CEO
Join us in congratulating Dr. Shrader on her new role!
About Dr. Stephanie Shrader, Director of General Toxicologic Pathology
Dr. Stephanie Shrader joined the StageBio team as a Senior Pathologist in 2019. She has a strong background and primary subspecialty interest in ocular pathology with extensive experience evaluating a variety of ophthalmic drugs, animal models, ocular dosing routes, and ocular medical devices. Prior to StageBio, Dr. Shrader spent two years at Charles River Laboratories in Spencerville, Ohio where she also served as the site’s IACUC chairperson. She is an active member of the American College of Veterinary Pathologists (ACVP) and the Society of Toxicologic Pathology (STP), enjoys collaborating with her colleagues to author book chapters and peer reviewed journal articles, and serves as a peer reviewer for several journals. Dr. Shrader earned a BS in Biological Sciences from Wilson College in Pennsylvania, a DVM from the Virginia-Maryland College of Veterinary Medicine and completed her anatomic pathology residency and PhD in Biomedical Sciences at the Auburn University College of Veterinary Medicine. Stephanie resides in Delphos, Ohio with her husband, Jeff, and their canine companions.
StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. We will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at stagebio.com.